# Studies Addressing Rare Neurodegenerative Diseases including ALS

Source: https://welltoldgrants.com/grants/for-fd-25-006-studies-addressing-rare-neurodegenerative-diseases/  
Official notice: https://www.grants.gov/search-results-detail/356046

> Food and Drug Administration plans to offer grants to any type of organization. It expects to make about 10 awards. It is a forecast, and no dates have been set yet.

| Field | Value |
|---|---|
| Opportunity number | FOR-FD-25-006 |
| Agency | Food and Drug Administration |
| Status | Forecast |
| Deadline | not set |
| Award ceiling | not stated |
| Award floor | not stated |
| Expected awards | 10 |
| Total funding | not stated |
| Cost sharing | not required |
| Assistance Listings | 93.103 |

## Who can apply

- State governments
- County governments
- City or township governments
- Special district governments
- Independent school districts
- Public and State controlled institutions of higher education
- Native American tribal governments (Federally recognized)
- Public housing authorities/Indian housing authorities
- Native American tribal organizations (other than Federally recognized tribal governments)
- Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
- Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
- Private institutions of higher education
- For profit organizations other than small businesses
- Small businesses
- Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled "Additional Information on Eligibility"

## What the grant funds

The purpose of this funding opportunity announcement (FOA) is to support studies that advance medical product development of interventions intended to prevent, diagnose, mitigate, treat, or cure ALS and other rare neurodegenerative diseases in adults and children. Through the support of these studies, FDA expects to address critical knowledge gaps, exert a significant impact on rare neurodegenerative diseases, and to inform current or future product development.

## Questions people ask

### Who can apply for Studies Addressing Rare Neurodegenerative Diseases including ALS?

Food and Drug Administration accepts applications from any type of organization.

### What is the deadline for Studies Addressing Rare Neurodegenerative Diseases including ALS?

Forecast, no dates yet. Confirm the date and time in the official notice on Grants.gov.